In the last few years, it has been seen that the pharmaceutical manufacturers have been paying a huge amount to doctors to promote the opioid drugs which have been now a national epidemic.
After the deaths of many people, the lawsuits and media have now accused the Purdue Pharma, who is the maker of OxyContin for its marketing. It is known to be a powerful narcotic drug which is even after it knew the drug was being misused. Prosecutors also charged the founder of Insys Therapeutics and other several company sales representatives along with the executives for their roles in a conspiracy to give bribe to doctors so that they will be using fentanyl spray for the unapproved uses.
After the state and local governments have sued some drugmakers for illegally marketing the opioids, now it was seen that it was retreating. As per the new ProPublica analysis, it shows that the pharmaceutical company payments are now decreasing hugely from last year.
In the year 2016, drugmakers have already spent $15.8 million to pay doctors for speaking, travel-related opioids drugs and consulting. This has been now down to about 33 percent which is from about $23.7 million in the year 2015 and is about 21 percent less than in 2014. The companies are now required to report the payments publicly under the Physician Payment Sunshine Act, which is a part of the 2010 Affordable Care Act.
ProPublica has analyzed the payments which are in conjunction with the update of Dollars for Docs. It is said to be an online tool which allows the users to view and compare all types of promotional payments for the doctors for the drugs and all types of medical device companies.
According to reports of Centers for Medicare and Medicaid Services, it shows that there is a sharp drop in use of prescribed opioids. These drugs are peaked at 81.7 million in 2014, followed by 80.2 million in 2015 and then to 79.5 million in 2016.